Atomoxetine Utilization in Youths with Attention Deficit/Hyperactivity Disorder in 29 Medicaid States

被引：0
|
作者：
Linden, Stephan [1 ]
Knox, Caitlin [1 ]
Winterstein, Almut G. [1 ]
机构：
[1] Univ Florida, Coll Pharm, Gainesville, FL USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
309
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [41] Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
    Moon, Su Jin
    Kim, Chang Ju
    Lee, Yeon Jung
    Hong, Minha
    Han, Juhee
    Bahn, Geon Ho
    PLOS ONE, 2014, 9 (10):
  • [42] Combination of Atomoxetine and Methylphenidate in Attention Deficit/Hyperactivity Disorder: A Case Report
    Agarwal, Vivek
    Sitholey, Prabhat
    JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2008, 17 (03) : 160 - 160
  • [43] Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder
    Barton, J
    ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 : I26 - I29
  • [44] Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescentsy
    Karly P. Garnock-Jones
    Gillian M. Keating
    CNS Drugs, 2010, 24 : 85 - 88
  • [45] Subcortical Differences among Youths with Attention-Deficit/Hyperactivity Disorder Compared to Those with Bipolar Disorder With and Without Attention-Deficit/Hyperactivity Disorder
    Lopez-Larson, Melissa
    Michael, Emily S.
    Terry, Janine E.
    Breeze, Janis L.
    Hodge, Steven M.
    Tang, Lena
    Kennedy, David N.
    Moore, Constance M.
    Makris, Nikos
    Caviness, Verne S.
    Frazier, Jean A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (01) : 31 - 39
  • [46] Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder
    Biederman, J
    Mick, E
    Faraone, SV
    JOURNAL OF PEDIATRICS, 1998, 133 (04): : 544 - 551
  • [47] Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder
    Sultan, Ryan S.
    Wang, Shuai
    Crystal, Stephen
    Olfson, Mark
    JAMA NETWORK OPEN, 2019, 2 (07)
  • [48] Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder
    Mark E. Bangs
    Ling Jin
    Shuyu Zhang
    Durisala Desaiah
    Albert J. Allen
    Holly A. Read
    Arie Regev
    Joachim F. Wernicke
    Drug Safety, 2008, 31 : 345 - 354
  • [49] Comment on: “Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder”
    Uday Pande
    Nitin R. Gaikwad
    Alok Singh
    CNS Drugs, 2023, 37 (10) : 937 - 938
  • [50] Effects of Exercise Intervention in Youths With Attention-Deficit Hyperactivity Disorder
    Pan, Chien-Yu
    Chang, Yu-Kai
    Tsai, Chia-Liang
    Chu, Chia-Hua
    RESEARCH QUARTERLY FOR EXERCISE AND SPORT, 2014, 85 : 83 - 84
12345